Biosynex Covid-19 Ag BSS Rapid Test
The antigen tests for COVID infection are relatively inexpensive, fast and suitable for Point-of-Care use. The performance of the tests depends much on how they are used. The antigen tests are most suitable when they are used as a diagnostic aid for persons who have recently become symptomatic and the virus load in the respiratory tract is high. Comprehensive evidence on usefulness in asymptomatic infected persons is not yet available.
General Guidance
Biosynex Covid-19 Ag BSS Rapid test is used as support to SARS-CoV-2 infection diagnosis for patients with clinical symptoms. The result should be considered only as an initial screening test result. The result of this test should not be the sole basis for the diagnosis; confirmatory testing is required.
Intended use
Biosynex Covid-19 Ag BSS Rapid test is a rapid in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
Benefits Biosynex Covid-19 Ag BSS Rapid Test
Ease of use
- Only few steps from sample to result
- All needed components are supplied with the test kit
- Room temperature storage
Excellent performance
- Compared to PCR relative Sensitivity 96%, Specificity 100%
- No cross-reactivity against other common respiratory viruses
Fast and flexible result
- The result is ready in 15 minutes, can be read up to 20 minutes
Technical data
| Method | Immunochromatographic, qualitative |
| Sample type | Nasopharyngeal swab |
| Time to result | 15 minutes |
| Reading of result | Visual |
| Sensitivity | 96% to PCR |
| Specificity | 100% to PCR |
| Storage | 2 - 30°C |
Documents and materials
Biosynex BSS COVID-19 Ag Rapid Test Brief instruction with Separate Buffer (EN)
Biosynex BSS COVID-19 Ag Rapid Test Brief instruction with Prefilled Buffer (EN)
Instructions for use
(For informative use only. Kindly always refer to the latest package insert in the kit.)